Market Update: The Procter & Gamble Company (NYSE:PG) – Market Opportunity and Discovery – Analyst Notes on Mondelez International, Marathon Petroleum, Procter & Gamble, and Avago Technologies

[Accesswire] – NEW YORK, NY / ACCESSWIRE / February 4, 2016 / Moments ago, Trader’s Choice released new research updates concerning several developing situations, including one of the leading uptrends in today’s market: … Read more on this. The Procter & Gamble Company (PG) , with a current value of $218.18B, started trading this morning at $80.85. Looking at today’s trading action, the company’s one day range from $80.02 to $81.24 and has traded between $65.02 and $86.78 over the past 12 months. Priced at 22.34x this year’s forecasted earnings, PG shares are relatively expensive compared to the industry ’s 18.11x forward p/e ratio. And for those looking to make a return holding the stock, the company pays shareholders $2.65 per share annually in dividends, yielding 3.25%. According to a consensus of 23 analysts, the earnings estimate of $0.82 per share would be $0.07 worse than the year-ago quarter and a $0.10 sequential decrease. What we find to be interesting is that the full-year EPS estimate of $3.63 is a $0.13 worse when compared to the previous year’s annual results. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $15.94 Billion. If realized, that would be a 12.13% decrease over the year-ago quarter. More recently, Stifel upgraded PG from Hold to Buy (Jan 19, 2016). Previously, Sun Trust Rbsn Humphrey upgraded PG from Neutral to Buy. The average price target for PG shares by the analysts covering it is $83.21, which is 2.92% above where the stock opened. See more in (NYSE:PG) Similar Articles: Market Update: The Procter & Gamble Company (NYSE:PG) – Dozens more companies join US pledge on climate change -W.House Company Update: The Procter & Gamble Company (NYSE:PG) – Procter & Gamble Commits to Helping 100 Million Girls and Women Build Confidence Company Update (NYSE:PG): Cleveland Clinic Partnering With Procter & Gamble And Cleveland HeartLab To Advance Discovery In Heart Disease